Abstract Introduction
In France, surveillance of early syphilis (primary, secondary and early latent) relies on the clinician-based ResIST sentinel network. Although ResIST enables the monitoring of trends, a complete picture of the syphilis epidemic is not possible. More specifically, cases reported by this network are mostly diagnosed in free STI clinics and hospitals (respectively, 75% and 24%). This study aims to estimate the number and rate of diagnoses made outside these health facilities by exploring health insurance data.
Methods
An algorithm combining healthcare reimbursements for specific diagnostic tests and recommended treatment was fitted to identify syphilis cases. Sensitivity analyses were used to validate the algorithm. Age and gender standardized diagnosis rates were estimated using census data.
Results
Between 2011 and 2013, 12 644 (7.5 cases per 100 000 inhabitants) reimbursements were made for syphilis-related diagnoses. The annual number of cases increased by 22% from 2011 (n=3 771, rate=6.7 / 100 000) to 2013 (n=4 589, rate=8.2 / 100 000). The rate of syphilis diagnosis increased in men from 12.9 /100 000 to 16 .0 / 100 000, while it remained steady in women at approximately 1.8 /100 000. The disease burden was greatest in French overseas territories (18.1 / 100 000) and in the Paris area (11.7 cases / 100 000).
Conclusion
Despite the lack of data on the number of confirmed diagnoses and information about sexual behaviour, these findings demonstrate the relevance of analysing insurance data to help monitor the syphilis epidemic in patients who visit general practitioners and non-hospital based specialists.
Limits of this study:
-lack of confirmed diagnoses and sexual behaviour information.
Strenght of this study:
-large coverage of the national health insurance in France, -comprehensiveness of reimbursement data -use of algorithm combining individual linkage of a specific treatment (BPG) and recommended combinations of TT and NTT to identify the cases. 
Introduction
Syphilis continues to be a major public health concern in France since its upsurge in 2000 1 .
The epidemic is predominantly spreading in men who have sex with men (MSM), who represent more than 80% of reported cases each year. Between 2013 and 2015, an increase of 56% was seen in this population. Despite much smaller numbers, a rise has also been observed in heterosexuals since 2012 2 .
Considering this uncontrolled situation, the fact that syphilis is a risk factor for HIV transmission, and its non-negligible associated complications (neurosyphilis, etc.), accurate epidemiological surveillance can help guide and evaluate prevention interventions in the context of pre-exposure prophylaxis for HIV infection [3] [4] [5] .
In France, national surveillance of early syphilis (primary, secondary and early latent (< 1 year) relies on the voluntary clinician-based network ResIST. It gathers demographic, clinical, biological and behavioural data 6 . Although surveillance data enable the monitoring of epidemiological trends and characteristics, they do not provide an accurate picture of the epidemic because of a lack of representativeness. The sensitivity and coverage of the ResIST sentinel network data have not yet been estimated, and reported cases are mostly diagnosed in free STI clinics (75% in 2014) and hospital consultations (24% in 2014) 2 given the small number of general practitioners and non-hospital based specialists in the network.
In order to complete the picture of the epidemic in France, this study aimed to estimate the contribution (number, rate and trends) of diagnoses made outside of free STI clinics and hospitals, by exploring health insurance data.
Methods

Study population:
The study population included all persons covered by the national health insurance system in France (approximately 63 million beneficiaries or approximately 95% of the population) 7 8 .
Health insurance data
The French health insurance databases are stored anonymously in a huge data-warehouse, the French national health insurance database ('Système national d'information inter-régime de l'assurance maladie' [SNIIR-AM]). SNIIR-AM contains data on healthcare reimbursements and sociodemographic information relative to each beneficiary. These data are linkable through a unique identifier encrypted and replaced by a non-reversible key in various databases 7 9 . The inter-scheme consumption data ('données de consommation interrégimes' [DCIR]), including non-hospital based healthcare reimbursements, was specifically used in this study.
The DCIR collects a large amount of information including demographic data (age, gender, place of residency, affiliate insurance scheme, etc.) and non-hospital based healthcare data (type of prescriber and dispenser, diagnostic test codes, drug codes, exact pharmaceutical form, number of dispensed units for each affiliated person), prospectively and daily 7 . Free STI healthcare, which are not collected in the DCIR, and hospital based diagnoses data were not analysed in this study 7 8 . 
Case definitions
As clinical details (i.e., symptoms, diagnostic results) are not collected in the DCIR, an algorithm combining reimbursements for diagnostic tests and treatments was fitted to identify syphilis cases ( Figure 1 ). Assuming that syphilis treatment is mainly prescribed over a 30-day period after diagnosis and that a duration of at least 365 days is observed between two episodes of syphilis in the same patient due to temporary immunity, we selected and combined reimbursement codes corresponding to the prescriptions according to syphilis screening and treatment guidelines [10] [11] [12] . Combinations of treponemal tests (TT: serologic tests (detection, titres), IgM
Immunoassays, tests to detect T. pallidum directly (darkfield examination or other test)) and non-treponemal tests (NTT: serologic tests (detection, titres)) preceding a prescription of benzathine penicillin G (BPG) up to 7.2 million units (MU) over 30 days defined three types of incident syphilis cases. The threshold of 7.2 MU (regimens for late syphilis) was chosen to identify any incident syphilis irrespective of its stage [10] [11] [12] [13] [14] .
Finally, three types of incident cases were defined according to the combinations of diagnostic tests ( Figure 1 This algorithm was validated after analysing the consistency of syphilitic tests and BPG prescription according to surveillance data. The study period was restricted to three years, from January 2011 to December 2013, before the stock depletion of BPG in France between 2014 and 2016. Sensitivity analyses completed the validation process, considering the distribution of BPG doses and the time between treatment and diagnosis reimbursement.
Statistical analysis
The annual number of identified syphilis cases was estimated. Cases were described according to age, gender and region of residence. Finally, age-and gender-standardized diagnosis rates were calculated for individuals aged 15 years and over using census data. SAS Enterprise guide 4.3 was used for statistical analyses. (Figure 2 ). The annual number of syphilis diagnoses increased by 22% from 2011 (n=3 771) to 2013 (n=4 589) ( Figure 3 ). Most were men ( 87% in 2011 and 89% in 2013). The men to women ratio was steady over time and higher for probable cases (8:1) than for certain and possible cases (respectively, 7:1 and 6:1). Most of the cases (75%) were treated with less than 7.2 MU of BPG.
Ethics statement
During the study period, the overall rate of diagnosis was estimated at 7.5 cases / 100 000 inhabitants aged 15 years and over ( Figure 4 ). It rose from 6.7 / 100 000 in 2011 to 8.2 / 100 000 in 2013. Between 2011 and 2013, a higher rate than the national level was estimated in 9 / 24 regions, with the highest burden observed in French overseas territories (18.1 diagnoses / 100 000) and in the Paris area (11.7 diagnoses / 100 000 inhabitants). Of these 9 regions, rates increased between 2011 and 2013 in Alsace, Provence-Alpes-Côte d'Azur and the Paris area, whereas it remained relatively stable in the other regions.
The rate of syphilis diagnosis increased in men from 12.9 /100 000 in 2011 to 16.0 / 100 000 in 2013 while it remained stabilized at approximately 1.8 /100 000 in women. During the study period, the highest rate of diagnoses (up to 26.2 / 100 000) was observed for men 40-44 years old ( Figure 5 ). The age structure shows that 92% of cases were between 15 and 59 years old in both sexes.
Discussion
Although the primary limitation of using reimbursement data is the lack of confirmed diagnoses numbers and sexual behaviour information, this type of proxy approach has already been validated using other algorithms in several contexts 7 16-18 . Several training sessions were prerequisites by the national health Insurance before getting the authorization to use the SNIIR-AM and to build the syphilis algorithm in this study 7 8 . But, any changes in the availability of diagnostic tests or BPG may impact the usage of this algorithm. Accordingly, updates could be necessary in such a situation (e.g., a temporary shortage of BPG). Nevertheless, the large coverage of health insurance in France 7 8 , the comprehensiveness of reimbursement data and individual linkage of a specific treatment (BPG) and recommended combinations of TT and NTT, demonstrate the relevance of using SNIIR-AM databases to monitor syphilis diagnoses in France.
Healthcare reimbursement data for the whole population covered by the national health insurance can therefore be used to estimate the number of individuals tested for syphilis, the number of cases, and positivity rates according to age, sex and region. These epidemiologic In our study, the annual gender distribution of syphilis cases was coherent with surveillance data in western European countries including France
3
. The high proportion of men (over 80%) corresponds to situations reported in Germany, Ireland, the Netherlands, Norway and the United Kingdom 3 . Nevertheless, proportions of women (11% in the national health insurance data in 2013) compared to 4% reported by the ResIST sentinel network might reflect differences between the populations using free STI services and those diagnosed by non-hospital-based physicians 6 . Performing a behavioural survey in the population diagnosed for syphilis and other STI by GP and non-hospital based physicians could be useful to know the characteristics of cases by transmission mode (MSM, heterosexual).
The predominance of women (at least 75%) among tested individuals each year in our study is coherent with findings from the antenatal syphilis detection program in France and the gender-based distribution of syphilis cases, with an overall male/female ratio close to 7, reflects the national surveillance results, demonstrating the relevance of using the algorithm. Moreover, the proportion of TT and NTT titer tests (99%) among reimbursed diagnostic tests is also consistent with the physicians' prescriptions in the surveillance data.
The distribution of cases by BPG dose shows that 75% of identified cases might be early syphilis cases (< 1 year), considering that BPG prescription was under 7.2 MU. Consequently, a quarter of syphilis diagnoses made outside of hospitals and free STI clinics in France may correspond to late syphilis cases, which are not currently monitored. These proportions are close to those found in US surveillance data 20 . Therefore, the surveillance of transmission dynamics (early syphilis) and delayed syphilis diagnosis (late syphilis) might be possible using insurance data.
The comprehensiveness of reimbursement data and their coverage enable spatial and temporal calculations at the regional level 21 22 . Accordingly, subnational surveillance is possible and standardized rates can be used to compare different areas. In this study the highest rates of syphilis were observed for French overseas territories, whereas the ResIST sentinel network currently underestimates the burden of the epidemic in those areas 6 . These rates are consistent with the findings of a laboratory survey conducted in 2012 which estimated the highest rates of gonorrhoea and chlamydial infections in the same areas 23 .
Despites differences in data collection techniques, reimbursement data confirm the results of network surveillance data by demonstrating that a quarter of annual cases of syphilis are reported in the Paris area 6 .
Conclusion
In France, a complete picture of the syphilis epidemic might result from summing the number of reimbursed diagnoses with diagnoses made in hospitals and free STI clinics. Annual incidence rate estimates could therefore help to accurately monitor the epidemic's evolution and guide prevention policies. Using reimbursement data could also help to monitor syphilis testing at the subnational level, to analyse local responses to the epidemic and to investigate outbreaks.
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Abstract Objectives
Methods
Results
Between 2011 and 2013, 12 644 (7.5 cases per 100 000 inhabitants) reimbursements were made for syphilis-related diagnoses. The annual number of cases increased by 22% from 2011 (n=3 771, rate=6.7 / 100 000) to 2013 (n=4 589, rate=8.2 / 100 000). The rate of syphilis diagnosis increased in men from 12.9 /100 000 to 16.0 / 100 000, while it remained steady in women at approximately 1.8 /100 000. The disease burden was greatest in French overseas territories (18.1 / 100 000) and in the Paris area (11.7 cases / 100 000).
Conclusion
Despite the lack of data on the number of confirmed diagnoses and information about sexual behaviour, these findings demonstrate the relevance of analysing insurance data to help monitor the syphilis epidemic in patients who visit general practitioners and non-hospital based specialists. Thus, reimbursement database might be relevant alternative source of continuous information on syphilis in countries with similar insurance-based healthcare systems.
Strenght and limitations of this study:
-Large coverage of the national health insurance in France (almost whole population).
-Comprehensiveness of reimbursement data.
-Algorithm combining individual linkage of a specific treatment (BPG) and recommended combinations of TT and NTT to identify cases as diagnostic results are not available. -Clinical details and sexual behaviour information are not collected in the reimbursement database. Considering this uncontrolled situation, the fact that syphilis is a risk factor for HIV transmission, and its non-negligible associated complications (neurosyphilis, etc.), accurate epidemiological surveillance can help guide and evaluate prevention interventions in the context of pre-exposure prophylaxis for HIV infection [3] [4] [5] .
In France, national surveillance of early syphilis (primary, secondary and early latent (< 1 year)) relies on the voluntary clinician-based network ResIST. It gathers demographic, clinical, biological and behavioural data 6 . Although surveillance data enable the monitoring of epidemiological trends and characteristics through consistently participating diagnosis centres, they do not provide an accurate picture of the epidemic because of a lack of representativeness. Indeed, reported cases are mostly diagnosed in free STI clinics (75% in 2014) and hospital consultations (24% in 2014) 2 given the small number of general practitioners and non-hospital based specialists in the network.
In France, free STI clinics are primarily targeting high risk groups and socially disadvantaged ones but anybody can visit these public facilities. Nevertheless, these STI clinics are commonly visited by aware population whereas most individuals are likely to seek care visiting general practitioners, private clinics or public hospitals, thanks to the national health insurance covering almost whole population.
Methods
Study population
Health insurance data
The French health insurance databases are stored anonymously in a huge data-warehouse, the French national health insurance database ('Système national d'information inter-régime de l'assurance maladie' [SNIIR-AM]). SNIIR-AM contains data on healthcare reimbursements and sociodemographic information relative to each beneficiary. These data are linkable through a unique identifier encrypted and replaced by a non-reversible key in various databases 7 9 . The inter-scheme consumption data ('données de consommation interrégimes' [DCIR]), including non-hospital based healthcare reimbursements, was specifically used in this study. The DCIR collects a large amount of information including demographic data (age, gender, place of residency, affiliate insurance scheme, etc.) and non-hospital based healthcare data (type of prescriber and dispenser, diagnostic test codes, drug codes, exact pharmaceutical form, number of dispensed units for each affiliated person), prospectively and daily 7 . Free STI healthcare, which are not collected in the DCIR, and hospital based diagnoses data were not analysed in this study 7 8 .
Case definitions
As clinical details (i.e., symptoms, diagnostic results) are not collected in the DCIR, an algorithm combining reimbursements for diagnostic tests and treatments was fitted to identify syphilis cases (Figure 1 ). Assuming that syphilis treatment is mainly prescribed over a 30-day period after diagnosis and that a duration of at least 365 days is observed between two episodes of syphilis in the same patient due to temporary immunity, we selected and combined reimbursement codes corresponding to the prescriptions according to syphilis screening and treatment guidelines [10] [11] [12] . Combinations of treponemal tests (TT: serologic tests (detection, titres), IgM
Finally, three types of incident cases were defined according to the combinations of diagnostic tests (Figure 1 This algorithm was validated after analysing the consistency of syphilitic tests and BPG prescription according to available data (estimated proportion of pregnant women tested for syphilis in 2011 and the annual number of births in France, number of BGP unit sales, syphilis male/female ratio, regions with highest HIV, chlamydial and gonococcal infections incidence (i.e overseas regions, Paris area)) [15] [16] [17] . The study period was restricted to three 
Statistical analysis
The annual number of identified syphilis cases was estimated. Cases were described according to age, gender and region of residence. Finally, age-and gender-standardized diagnosis rates were calculated for individuals aged 15 years and over using census data. SAS Enterprise guide 4.3 was used for statistical analyses.
Ethics statement
Ethical approval was granted by the French Data Protection Agency (CNIL) with decrees dated 20th June 2005 and 1st December 2011. These decrees strictly restrict access to anonymized SNIIR-AM data to accredited analysts 18 . Therefore, no individual consent was required for this study.
Patient and Public Involvement
Patients and the public were not involved in the design and the conduct of the study. . The men to women ratio was steady over time and higher for probable cases (8:1) than for certain and possible cases (respectively, 7:1 and 6:1). Most of the cases (75%) were treated with less than 7.2 MU of BPG.
Results
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Discussion
Although the primary limitation of using reimbursement data is the lack of biological results, clinical details and sexual behaviour information, this type of proxy approach has already been validated using other algorithms in several contexts 7 19-21 . Several training sessions were prerequisites by the national health Insurance before getting the authorization to use the SNIIR-AM and to build the syphilis algorithm in this study 7 8 . But, any changes in the availability of diagnostic tests or BPG may impact the usage of this algorithm. Accordingly, updates could be necessary in such a situation (e.g. a temporary shortage of BPG requires to add replacement drugs in the algorithm). Nevertheless, the large coverage of health insurance in France (almost whole population) 7 8 , the comprehensiveness of reimbursement data and individual linkage of a specific treatment (BPG) and recommended combinations of TT and NTT, demonstrate the relevance of using SNIIR-AM databases to monitor syphilis diagnoses in France.
Healthcare reimbursement data for the whole population covered by the national health insurance can therefore be used to estimate the number of individuals tested for syphilis, the number of cases, and positivity rates according to age, sex and region. These epidemiologic indicators are easily understandable. They enable trends to be precisely monitored over time, especially at a local level. Instead, trends based on sentinel networks data in France are currently difficult to interpret precisely without information about the participation level and the networks' sensitivity.
The sharp increase in the rate of diagnoses (from 6.7 /100 000 to 8.8 / 100 000 between 2011 and 2013) reflects the rising trends in syphilis epidemic observed in western European countries comparable to France 3 . This increase might result from a growing tendency towards more risky sexual behaviour. However, these numbers of diagnoses and rates almost certainly underestimate the disease burden as they exclude undiagnosed cases, hospital based diagnoses and diagnoses provided in free STI clinics.
Our results -notably the number of annual cases (4 589 in 2013) compared to incidence in other European countries (4 656 cases in the United Kingdom, 3 568 cases in Spain and 5 718 cases in Germany in 2014 3 ) -demonstrate that general practitioners (GP) and nonhospital based specialists still play a role in STI management in France. Consequently, health insurance data should be used to complement incidence estimates. A study using the UK Clinical Practice Research Datalink anonymous primary care records service found similar findings for chlamydial infections and gonorrhoea in England 22 .
In our study, the annual gender distribution of syphilis cases was coherent with surveillance data in western European countries including France
3
. The high proportion of men (over 80%) corresponds to situations reported in Germany, Ireland, the Netherlands, Norway and the United Kingdom 3 . Nevertheless, proportions of women (11% in the national health insurance data in 2013) compared to 4% reported by the ResIST sentinel network might reflect differences between the populations using free STI services and those diagnosed by non-hospital-based physicians 6 . Performing a behavioural survey in the population diagnosed for syphilis and other STI by GP and non-hospital based physicians could be useful to know the characteristics of cases by transmission mode (MSM, heterosexual). The predominance of women (at least 75%) among tested individuals each year in our study is coherent with findings from the antenatal syphilis detection program in France (90% of pregnant women were tested for syphilis in 2011; less than 800 000 annual live births in France) and the gender-based distribution of syphilis cases, with an overall male/female ratio close to 7, reflects the national surveillance results (more than 80% men among syphilis cases reported in the ResIST network), demonstrating the relevance of using the algorithm 2 15-17 . Moreover, the proportion of TT and NTT titer tests (99%) among reimbursed diagnostic tests is also consistent with the physicians' prescriptions in the surveillance data.
The distribution of cases by BPG dose shows that 75% of identified cases might be early syphilis cases (< 1 year), considering that BPG prescription was under 7.2 MU. Consequently, a quarter of syphilis diagnoses made outside of hospitals and free STI clinics in France may correspond to late syphilis cases, which are not currently monitored. These proportions are close to those found in US surveillance data 23 . Therefore, the surveillance of transmission dynamics (early syphilis) and delayed syphilis diagnosis (late syphilis) might be possible using insurance data.
The comprehensiveness of reimbursement data and their coverage enable spatial and temporal calculations at the regional level 24 25 . Accordingly, subnational surveillance is possible and standardized rates can be used to compare different areas. In this study the highest rates of syphilis were observed for French overseas territories, whereas the ResIST sentinel network currently underestimates the burden of the epidemic in those areas 6 . These rates are consistent with the findings of a laboratory survey conducted in 2012 which estimated the highest rates of gonorrhoea and chlamydial infections in the same areas 26 .
Conclusion
In France, a complete picture of the syphilis epidemic might result from summing the number of reimbursed diagnoses with diagnoses made in hospitals and free STI clinics. Annual incidence rate estimates could therefore help to accurately monitor the epidemic's evolution and guide prevention policies. Using reimbursement data could also help to monitor syphilis testing at the subnational level, to analyse local responses to the epidemic and to investigate outbreaks. Thus, healthcare reimbursement database might be relevant alternative source of continuous information on syphilis in countries with similar insurance-based healthcare systems. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 21 Discuss the generalisability (external validity) of the study results
Other information Funding
Page 8
22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based *Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
